Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lori A. Fix, Ph.D., DABT®, and James W. Cox, MS, Join Bergeson & Campbell, P.C. and The Acta Group


News provided by

Bergeson & Campbell, P.C.

Aug 05, 2022, 08:00 ET

Share this article

Share toX

Share this article

Share toX


Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Lori A. Fix, Ph.D., DABT®, and James W. Cox, MS, have joined our firms as Senior Scientists.

WASHINGTON, Aug. 5, 2022 /PRNewswire-PRWeb/ -- Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Lori A. Fix, Ph.D., DABT®, and James W. Cox, MS, have joined our firms as Senior Scientists. Dr. Fix is a gifted toxicologist and safety assurance professional with a long track record of success at globally dominant brands in the consumer products, foods, and pesticides industries. Mr. Cox is an experienced biologist and risk assessor who has reviewed hundreds of industrial chemicals, biological agents, nanomaterials, and novel chemistries in his roles with the U.S. Environmental Protection Agency (EPA).

Over the course of her stellar career, Lori A. Fix, Ph.D., DABT®, has developed and executed risk assessment, safety assurance, and regulatory compliance efforts at the highest levels of some of the world's largest agricultural, food, and consumer goods companies, including Reckitt Benckiser, Unilever, and Bayer Crop Science. As a proven scientific manager, strategic planner, and project leader, Dr. Fix is a powerful asset to clients seeking successful and persistent outcomes for products and companies engaged with EPA, the U.S. Food and Drug Administration (FDA), the European Chemicals Agency (ECHA), and regulations and codes, including the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Food Quality Protection Act (FQPA), California's Proposition 65, the Cosmetic, Toiletry and Fragrance Association (CTFA) (now the Personal Care Products Council) Consumer Commitment Code (2006), ASEAN Cosmetic Directive (2007), and the European Union (EU) Cosmetic Directive.

Lori A. Fix, Ph.D., and James W. Cox, M.S., join a powerful scientific and regulatory team at B&C and Acta, including eight Ph.D.s and nine EPA alumni.

Post this

In addition to her corporate leadership positions, Dr. Fix's global leadership roles in the field of safety assurance include serving as Chair of the Chemical Management Committee of the former Grocery Manufacturers Association (GMA) (now the Consumer Brands Association), past Chair of the Society of Toxicology Placement Committee, and as a representative on the International Life Sciences Institute (ILSI) Life Sciences Committee for Food and Chemical Safety. Dr. Fix earned a Ph.D. in Toxicology from North Carolina State University and an MS in Entomology from Texas A&M.

James W. Cox, MS, most recently served as Acting Lead Biologist in Risk Assessment Branch 1, New Chemicals Division, EPA's Office of Pollution Prevention and Toxics (OPPT), having held positions of increasing responsibility and scope since joining OPPT. He served as Chair of the Risk Assessment Division's (RAD) Hazard and Risk Assessment Technical Team and was a key member of the team providing analysis and recommendations to inform EPA's Office of Chemical Safety and Pollution Prevention's (OCSPP) policy on new approach methodologies (NAM).

Mr. Cox offers clients technical excellence and seasoned regulatory process guidance for products subject to the Toxic Substances Control Act (TSCA), FIFRA, and other federal and state chemical regulatory programs. Mr. Cox provides expertise in the collection and analysis of data; the design, evaluation, and development of models; and the presentation of scientific data in a clear and defensible manner to support chemical submissions.

Prior to his career at EPA OPPT, Mr. Cox was a biologist with the U.S. Department of Defense (DoD), serving in the toxicology directorate of the U.S. Army Public Health Center at Aberdeen Proving Ground, Maryland, and a public safety officer with the State of Maryland.

Lori A. Fix, Ph.D., and James W. Cox, M.S., join a powerful scientific and regulatory team at B&C and Acta, including eight Ph.D.s and nine EPA alumni. This nimble and talented team offers clients an unmatched wealth of experience and unparalleled record of scientific, legislative, and business accomplishment for substances and products regulated by TSCA, FIFRA, and global chemical analogs.

About Bergeson & Campbell, P.C. -- Located in Washington, D.C., B&C is a law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product regulation and approval and associated business issues. Additional information is available at http://www.lawbc.com.

About The Acta Group -- Acta, a consulting affiliate of B&C with offices in Washington, D.C., Brussels, Belgium, and Manchester, United Kingdom, offers expertise with regulatory programs and chemical product approvals in North America, South and Central America, Europe, Asia, and Eurasia. Acta supports clients' products from concept to approval so they get to market quickly and efficiently. Additional information is available at http://www.actagroup.com.

Media Contact

Heidi Lewis, Bergeson & Campbell, P.C., 202-557-3812, [email protected]

SOURCE Bergeson & Campbell, P.C.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.